Endpoints News 生物医药· ENDPOINTS·· 2026-10-15AI 评分19
阿斯利康与 inVIOs 达成 AI 药物发现合作;inVIOs 实体瘤 I 期试验成功
AstraZeneca does AI deal with insitro; inVIOs' Phase 1 success in solid tumors
AI 导读
AstraZeneca 与 insitro 达成 AI 药物发现合作协议。inVIOs 的 I 期临床试验在实体瘤中取得成功。此外,文章还提及了 ImmunityBio、Modus Therapeutics 和 Hyperway Pharmaceutical 的最新动态。
正文
Plus news about ImmunityBio, Modus Therapeutics and Hyperway Pharmaceutical.
AstraZeneca strikes AI drug discovery deal with insitro: The pharma giant will …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news